Coronavirus impact | IIT-JEE Advanced 2020 won't be held in foreign centres

Eligible candidates staying abroad have to select their preferred choices from the list of exam cities in India.

Moneycontrol News

August 03, 2020 / 21:45 IST

The Indian Institute of Technology (IIT) Delhi announced on July 31 that the Joint Entrance Examination (JEE) Advanced will not be conducted in foreign examination centres this year in view of the ongoing coronavirus pandemic. The entrance exam for admission to IITs is being conducted by IIT Delhi this year.

The official statement read: “Due to the current restrictions imposed on foreign travel and visa issuance, it is decided not to conduct JEE Advanced 2020 in foreign centres.”

“All eligible candidates staying abroad may select their preferred choices from the list of exam cities in India for taking JEE Advanced 2020,” the statement added.

The JEE Advanced 2020 is scheduled to be held on September 27, 2020. Usually, the examination is conducted in the month of May or June, but it had to be postponed this year due to the coronavirus outbreak. To make up for the time lost, IITs will be reducing the number of counselling rounds. They also plan to release the JEE 2020 results within a few days after the exam is conducted.

Students have been demanding further postponement of both engineering and medical entrance exams on health and safety grounds. The authorities have not changed the JEE Advanced exam schedule yet. They have, however, decided to relax the eligibility criteria for the exams in view of the academic loss due to the pandemic outbreak and the alternative assessment schemes adopted by different schools since most final exams could not be conducted.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show